HAVN Life Sciences Inc. announced the appointment of Mr. Gary Leong to its Board of Directors. Concurrently, Mr. Leong has stepped down as HAVN Life's Chief Science Officer, shifting his focus to an advisory role within the organization. Mr. Leong has been instrumental in the regulatory development and launch of HAVN Life's Retail Division, formulating its portfolio of natural health products, launched in June of 2021.

Gary Leong has more than thirty years of experience in the pharmaceutical and natural health product industries. Mr. Leong is currently acting as the Director of Quality  and Compliance at the privately Licensed Cannabis Processor, Tricanna Industries Inc. He was the Chief Scientific Officer at Aphria Inc. in Leamington, ON from its inception in 2014 to 2019, where he established and oversaw the Quality Assurance, Quality Control, Regulatory Affairs and Research and Development functions. Prior to this, he served as the Chief Scientific Officer of Jamieson Laboratories in Windsor, ON for fourteen years.

He has also managed the scientific and quality functions for Boehringer Ingelheim, Natural Factors Nutritional Products Ltd. and Nordion.